An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma

By Hartmann J.   Oechsle K.   Huober J.   Jakob A.   Azemar M.   Horger M.   Kanz L.   Bokemeyer C.  

Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. : 249-253

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial

By Knowling M.   Blackstein M.   Tozer R.   Bramwell V.   Dancey J.   Dore N.   Matthews S.   Eisenhauer E.  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 435-439

Springer Publishing Company

Access to resources Recommend Favorite

An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcoma

By Reichardt Peter   Oechsle Karin   Pink Daniel   Bokemeyer Carsten   Schneller F.   Issels Rolf   Kanz Lothar   Hartmann Jörg Thomas  

Investigational New Drugs, Vol. 21, Iss. 4, 2003-11 ,pp. : 481-486

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trial

By Pacey Simon  

Investigational New Drugs, Vol. 29, Iss. 3, 2011-06 ,pp. : 481-488

Springer Publishing Company

Access to resources Recommend Favorite

Phase II and Pharmacological Study of Oral Docetaxel Plus Cyclosporin A in Anthracycline Pre-Treated Metastatic Breast Cancer

By  

Current Clinical Pharmacology, Vol. 9, Iss. 2, 2014-05 ,pp. : 139-147

Bentham Science Publishers

Access to resources Recommend Favorite